User Safety: safe
Also Read
- Biomea Fusion Announces Phase 1 Data on Oral GLP-1 Agonist BMF-650 for Weight Management
- Houthi missiles intercepted over Saudi Arabia as battles intensify
- AbbVie Announces Phase 3 AFFIRM Trial Data: Skyrizi Achieves 35.8% Endoscopic Remission in Crohn’s Disease
- Army Establishes Futures and Autonomy Command to Accelerate Unmanned Systems Integration


